Publicaciones en colaboración con investigadores/as de Universidad Complutense de Madrid (24)

2024

  1. Diagnóstico y tratamiento de los trastornos de la presión intracraneal: Documento de consenso del Grupo de Estudio de Cefaleas de la Sociedad Española de Neurología

    Neurologia

2023

  1. Development of a predictive model of venous thromboembolism recurrence in anticoagulated cancer patients using machine learning

    Thrombosis Research, Vol. 228, pp. 181-188

  2. Diagnosis and treatment of trigeminal neuralgia: Consensus statement from the Spanish Society of Neurology's Headache Study Group

    Neurologia, Vol. 38, pp. S37-S52

2022

  1. Calcitonin gene–related peptide in migraine: from pathophysiology to treatment

    Neurologia, Vol. 37, Núm. 5, pp. 390-402

  2. Venous Thrombosis within 30 Days after Vaccination against SARS-CoV-2 in a Multinational Venous Thromboembolism Registry

    Viruses, Vol. 14, Núm. 2

2021

  1. Document of revision and updating of medication overuse headache (MOH)

    Neurologia, Vol. 36, Núm. 3, pp. 229-240

  2. Profiles of patients with venous thromboembolic disease in the emergency department and their medium-term prognosis: Data from the ESPHERIA registry

    Emergencias, Vol. 33, Núm. 2, pp. 107-114

  3. Safety of anti-CGRP monoclonal antibodies in patients with migraine during the COVID-19 pandemic: Present and future implications

    Neurologia, Vol. 36, Núm. 8, pp. 611-617

  4. Tumor cells in light-chain amyloidosis and myeloma show distinct transcriptional rewiring of normal plasma cell development

    Blood, Vol. 138, Núm. 17, pp. 1583-1589

2020

  1. A Role for MMP-10 (Matrix Metalloproteinase-10) in Calcific Aortic Valve Stenosis

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 40, Núm. 5, pp. 1370-1382

  2. Erratum: G protein–coupled receptor kinase 2 plays a relevant role in insulin resistance and obesity (Diabetes, (2010) 59, (2407-2417), 10.2337/db10-0771)

    Diabetes

  3. Evidence of and experience with the use of onabotulinumtoxinA in trigeminal neuralgia and primary headaches other than chronic migraine

    Neurologia, Vol. 35, Núm. 8, pp. 568-578

2019

  1. Evidence and experience with onabotulinumtoxinA in chronic migraine: Recommendations for daily clinical practice

    Neurologia, Vol. 34, Núm. 6, pp. 408-417

2018

  1. Causes of Death in Patients with Venous Thromboembolism Anticoagulated with Direct Oral Anticoagulants: A Systematic Review and Meta-Analysis

    Seminars in Thrombosis and Hemostasis, Vol. 44, Núm. 4, pp. 377-387

  2. Galectin-3 down-regulates antioxidant peroxiredoxin-4 in human cardiac fibroblasts: A new pathway to induce cardiac damage

    Clinical Science, Vol. 132, Núm. 13, pp. 1471-1485

  3. MPGES-1 (Microsomal prostaglandin E synthase-1) mediates vascular dysfunction in hypertension through oxidative stress

    Hypertension, Vol. 72, Núm. 2, pp. 492-502

2016

  1. Efficacy of Alteplase in a Mouse Model of Acute Ischemic Stroke: A Retrospective Pooled Analysis

    Stroke, Vol. 47, Núm. 5, pp. 1312-1318

2015

  1. Case Fatality Rates of Recurrent Thromboembolism and Bleeding in Patients Receiving Direct Oral Anticoagulants for the Initial and Extended Treatment of Venous Thromboembolism

    Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 20, Núm. 5, pp. 490-500

  2. Direct-acting oral anticoagulants: Pharmacology, indications, management, and future perspectives

    European Journal of Haematology, Vol. 95, Núm. 5, pp. 389-404

2014

  1. Direct oral anticoagulants in the treatment of acute venous thromboembolism: A systematic review and meta-analysis

    Thrombosis Research, Vol. 134, Núm. 4, pp. 774-782